From the Bench, July 2024: Fighting Chemo Brain With Light, Controlling Cancer Cell Death, and More
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
Roughly 6 percent of men and women in the United States will be diagnosed with lung and bronchus cancer...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
Guest post by Emil Lou, MD, PhD On October 7, 2020, the world awoke to news that the Royal...
For October’s installment of Editors’ Picks, the AACR journal editors have selected studies that feature results from two phase...
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete,...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
This month, the editors of the AACR’s journals have chosen to highlight an analysis of birth characteristics and risk...